Remimazolam for Emergence Delirium Prevention in Patients Undergoing Rhinoseptoplasty, FESS or Septoplasty

NCT06398275 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Remimazolam
Emergence Delirium
Rhinoplasty

Interventions

DRUG: Remimazolam 20 MG Injection [Byfavo]
DRUG: NaCl 0.9%

Sponsor

University Hospital of Split